Literature DB >> 14971118

How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions.

Philip S Wang1, Joshua S Benner, Robert J Glynn, Wolfgang C Winkelmayer, Helen Mogun, Jerry Avorn.   

Abstract

PURPOSE: To address poor patient compliance with antihypertensives, clinicians and researchers need accurate measures of adherence with prescribed regimens. Although self-reports are often the only means available in routine practice, their accuracy and agreement with other data sources remain questionable.
METHODS: A telephone survey was conducted on 200 hypertensive patients treated with a single antihypertensive agent in a large health maintenance organization (HMO) or a Veterans Affairs medical center (VAMC) to obtain self-reports of the frequency of missing antihypertensive therapy. We then analyzed records of all filled prescriptions to calculate the number of days that patients actually had antihypertensive medications available for use. Agreement between the two data sources was measured with correlation coefficients and kappa statistics. Logistic regression models were used to identify demographic, clinical and psychosocial correlates of overstating compliance.
RESULTS: There was very poor agreement between self-reported compliance and days actually covered by filled prescriptions (Spearman correlation coefficient = 0.15; 95%CI: 0.01, 0.28). Very poor agreement was also observed between a categorical measure of self-reported compliance (ever vs. never missing a dose) and categories of actual compliance defined by filled prescriptions (< 80% vs > 80% of days covered; kappa = 0.12, 95%CI: -0.02, 0.26). Surprisingly, few factors were associated with inaccurate self-reporting in either crude or adjusted analyses; fewer visits to health care providers was significantly associated with overstating compliance.
CONCLUSIONS: Compliance was markedly overstated in this sample of patients and few characteristics identified those who reported more versus less accurately. Clinicians and researchers who rely on self-reports should be aware of these limits and should take steps to enhance their accuracy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14971118     DOI: 10.1002/pds.819

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  28 in total

1.  Medication non-adherence after myocardial infarction: an exploration of modifying factors.

Authors:  Matthew J Crowley; Leah L Zullig; Bimal R Shah; Ryan J Shaw; Jennifer H Lindquist; Eric D Peterson; Hayden B Bosworth
Journal:  J Gen Intern Med       Date:  2015-01       Impact factor: 5.128

Review 2.  Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices.

Authors:  Lizheng Shi; Jinan Liu; Yordanka Koleva; Vivian Fonseca; Anupama Kalsekar; Manjiri Pawaskar
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

3.  Race/ethnic and sex differentials in pulse pressure among us adults.

Authors:  Richard G Rogers; Jarron M Saint Onge
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

4.  Self-reported pain sensitivity: lack of correlation with pain threshold and tolerance.

Authors:  Robert R Edwards; Roger B Fillingim
Journal:  Eur J Pain       Date:  2006-11-22       Impact factor: 3.931

5.  Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data.

Authors:  Jean Lachaine; Robert J Petrella; Elizabeth Merikle; Farzad Ali
Journal:  Can J Cardiol       Date:  2008-04       Impact factor: 5.223

6.  Learning to detect and understand drug discontinuation events from clinical narratives.

Authors:  Feifan Liu; Richeek Pradhan; Emily Druhl; Elaine Freund; Weisong Liu; Brian C Sauer; Fran Cunningham; Adam J Gordon; Celena B Peters; Hong Yu
Journal:  J Am Med Inform Assoc       Date:  2019-10-01       Impact factor: 4.497

7.  Endocrine therapy adherence: a cross-sectional study of factors affecting adherence and discontinuation of therapy.

Authors:  E M Quinn; C Fleming; M J O'Sullivan
Journal:  Ir J Med Sci       Date:  2015-05-14       Impact factor: 1.568

Review 8.  Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices: An Updated Review.

Authors:  Alisha Monnette; Yichen Zhang; Hui Shao; Lizheng Shi
Journal:  Pharmacoeconomics       Date:  2018-01       Impact factor: 4.981

9.  High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany.

Authors:  Stefan Feiten; Geothy Chakupurakal; Hans Peter Feustel; Michael Maasberg; Burkhard Otremba; Peter Ehscheidt; Manfred Hensel; Richard Hansen; Rudolf Weide
Journal:  Support Care Cancer       Date:  2019-03-11       Impact factor: 3.603

Review 10.  Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis.

Authors:  Lizheng Shi; Jinan Liu; Vivian Fonseca; Philip Walker; Anupama Kalsekar; Manjiri Pawaskar
Journal:  Health Qual Life Outcomes       Date:  2010-09-13       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.